APA (7th ed.) Citation

DV, F., JJ, M., DN, N., D, C., SU, S., JM, H., . . . RC, W. (2023). Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes. Nature biomedical engineering, 7(5), 647. https://doi.org/10.1038/s41551-023-01032-2

Chicago Style (17th ed.) Citation

DV, Foss, et al. "Peptide-mediated Delivery of CRISPR Enzymes for the Efficient Editing of Primary Human Lymphocytes." Nature Biomedical Engineering 7, no. 5 (2023): 647. https://doi.org/10.1038/s41551-023-01032-2.

MLA (9th ed.) Citation

DV, Foss, et al. "Peptide-mediated Delivery of CRISPR Enzymes for the Efficient Editing of Primary Human Lymphocytes." Nature Biomedical Engineering, vol. 7, no. 5, 2023, p. 647, https://doi.org/10.1038/s41551-023-01032-2.